Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Pneumococcal Vaccine for Sickle Cell Disease: Importance & Benefits

Pneumococcal Vaccine for Sickle Cell Disease: Importance & Benefits

December 10, 2025 Jennifer Chen Health

Okay, here’s a breakdown of the⁣ provided text, focusing on the key information about the study. ‌ I’ll organize⁢ it into sections ⁢for clarity.

1. Study⁣ Overview

* ⁣‌ Type: Retrospective, observational study.
* Location: Geneva University Hospitals, Switzerland.
* ⁣ ⁣ Population: ​ Children diagnosed with Sickle‍ Cell Disease ‍(SCD) aged less than‍ 16 ‌years at diagnosis.
* Timeframe: Data⁣ collected from 2009-2023 (diagnosis), with ‍patient follow-up from August 2007⁣ to September 2023.
* ⁣ Focus: Investigating pneumococcal seroprotection (immunity) in ‌SCD patients.

2.⁢ Methods & parameters

* Eligibility: ⁢Patients needed pneumococcal vaccine⁤ serology results available.
* ‍ Serology Tests: Antibodies ⁤to ​ Streptococcus pneumoniae ⁣ were measured ‍for⁤ serotypes 14F, 19F, and⁤ 23F ⁢(found in the Prevenar13 vaccine).
* Seroprotection Definition: ‍IgG levels ​> 0.30 mg/L against at​ least 2‌ of⁣ the 3 tested serotypes.
* ‌ Groups: Patients were‍ divided into two groups based on whether they ​received a booster dose ⁢of the pneumococcal vaccine in addition ⁢to the⁤ primary series.
* ⁣ Sample ‌size:

‍ ⁣ * Initially 42 children with ‌SCD were followed.
* 8 patients lacked vaccination records, leaving 32 for ‌analysis of vaccination status.

3. Patient Characteristics (of the 42 initially followed)

* 56% had received blood transfusions.
* 76% ⁣were⁣ treated ⁢with hydroxyurea.
* 12% ⁣had‍ a⁣ splenectomy.

4.⁢ Key ⁣Findings

*​ ‌ Vaccination Status: All ​patients with available records were fully ⁢vaccinated according to ‍thier age.
* Booster Doses: 44% (15/34) of patients received ‍at least one booster ⁤dose (median age 3.47 years).
* Vaccination ‍Frequency: Patients received an average of 3 pneumococcal vaccines, spaced every 1-2 years.
* Serology‍ Timing: Serology tests were performed when patients were⁢ an ⁤average‍ of 6 years old.
* Lack of immunity: 29% of patients with available immunization records showed no immunity ⁣against pneumococcus,despite⁣ being up-to-date on vaccinations.
* ⁢ further Analysis: A ⁣Kaplan-Meier (KM) analysis ‌was performed⁤ (the results of which are not included in this excerpt).

Image Description:

The text includes​ a 3D illustration of‍ sickle‍ cell anemia, showing a normal blood vessel⁣ alongside one with⁢ deformed, crescent-shaped red blood cells. The image credit is ⁣given to tussik – stock.adobe.com.

Let me‍ know if you’d like me to elaborate on any specific aspect of this information, or ‌if you have further questions.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service